{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T17:50:24Z","timestamp":1773683424970,"version":"3.50.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2008,3,18]],"date-time":"2008-03-18T00:00:00Z","timestamp":1205798400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1007\/s00432-008-0378-2","type":"journal-article","created":{"date-parts":[[2008,3,17]],"date-time":"2008-03-17T16:00:59Z","timestamp":1205769659000},"page":"1143-1149","source":"Crossref","is-referenced-by-count":43,"title":["Baseline elevated leukocyte count in peripheral blood is associated with poor survival in patients with advanced non-small cell lung cancer: a prognostic model"],"prefix":"10.1007","volume":"134","author":[{"given":"C.","family":"Tibaldi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Vasile","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Bernardini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Orlandini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Andreuccetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Falcone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,3,18]]},"reference":[{"key":"378_CR7","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1200\/JCO.2003.12.038","volume":"17","author":"V Alberola","year":"2003","unstructured":"Alberola V, Camps C, Provencio M, Isla D, Rosell R, Vadell C, Bover I, Ruiz-Casado A, Azagra P, Jimenez U, Gonzalez-Larriba JL, Diz P, Cardenal F, Artal A, Carrato A, Morales S, Sanchez JJ, de las Penas R, Felip E, Lopez-Vivanco G, Spanish Lung Cancer Group (2003) Cisplatin plus gemcitabine versus a cisplatin-based triplet versus nonplatinum sequential doublets in advanced non-small-cell lung cancer: a Spanish lung cancer group phase III randomized trial. J Clin Oncol 17:3207\u20133213","journal-title":"J Clin Oncol"},{"key":"378_CR11","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/sj.bjc.6600768","volume":"88","author":"J Atzpodien","year":"2003","unstructured":"Atzpodien J, Royston P, Wandert T, Reitz M (2003) Metastatic renal carcinoma comprehensive prognostic system. Br J Cancer 88:348\u2013353","journal-title":"Br J Cancer"},{"key":"378_CR2","unstructured":"Bunn PA Jr, Kelly K (1998) New chemotherapeutic agents prolong survival and improve quality of life in non-small cell lung cancer: a review of the literature and future directions. Clin Cancer Res 4:1087\u20131100"},{"key":"378_CR5","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","volume":"34","author":"DR Cox","year":"1972","unstructured":"Cox DR (1972) Regression models and life tables. J R Stat Soc 34:187\u2013220","journal-title":"J R Stat Soc"},{"key":"378_CR14","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1200\/JCO.2004.08.001","volume":"22","author":"G Giaccone","year":"2004","unstructured":"Giaccone G, Herbst RS, Manegold C, Scagliotti G, Rosell R, Miller V, Natale RB, Schiller JH, Von Pawel, Pluzanska A, Gatzemeier U, Grous J, Ochs JS, Averbuch SD, Wolf MK, Rennie P, Fandi A, Johnson DH (2004) Gefitinib in combination with gemcitabine and cisplatin in advanced non-small-cell lung cancer: a phase III trial\u2013INTACT 1. J Clin Oncol 22:777\u2013784","journal-title":"J Clin Oncol"},{"key":"378_CR13","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1200\/JCO.2004.07.215","volume":"22","author":"RS Herbst","year":"2004","unstructured":"Herbst RS, Giaccone G, Schiller JH, Natale RB, Miller V, Manegold C, Scagliotti G, Rosell R, Oliff I, Reeves JA, Wolf MK, Krebs AD, Averbuch SD, Ochs JS, Grous J, Fandi A, Johnson DH (2004) Gefitinib in combination with paclitaxel and carboplatin in advanced non-small-cell lung cancer: a phase III trial\u2013INTACT 2. J Clin Oncol 22:785\u2013794","journal-title":"J Clin Oncol"},{"key":"378_CR1","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3322\/canjclin.56.2.106","volume":"56","author":"A Jemal","year":"2006","unstructured":"Jemal A, Siegel R, Ward E et al (2006) Cancer statistics, 2006. CA Cancer J Clin 56:106\u2013130","journal-title":"CA Cancer J Clin"},{"key":"378_CR3","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s00432-003-0471-5","volume":"129","author":"B Jeremic","year":"2003","unstructured":"Jeremic B, Milicic B, Dagovic A, Aleksandrovic J, Nikolic N (2003) Pretreatment clinical prognostic factors in patients with stage IV non-small cell lung cancer (NSCLC) treated with chemotherapy. J Cancer Clin Oncol 129:114\u2013122","journal-title":"J Cancer Clin Oncol"},{"key":"378_CR4","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"EL Kaplan","year":"1958","unstructured":"Kaplan EL, Meier P (1958) Non parametric estimation from incomplete observations. J Am Stat Assoc 53:457\u2013481","journal-title":"J Am Stat Assoc"},{"key":"378_CR9","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1002\/1097-0142(20011101)92:9<2399::AID-CNCR1588>3.0.CO;2-W","volume":"92","author":"I Kasuga","year":"2001","unstructured":"Kasuga I, Makino S, Kiyuokawa H, Katoh H, Ebihara Y, Ohyashiki K (2001) Tumor-related leukocytosis is linked with poor prognosis in patients with lung carcinoma. Cancer 92:2399\u20132405","journal-title":"Cancer"},{"key":"378_CR15","doi-asserted-by":"crossref","first-page":"3578","DOI":"10.1200\/JCO.2002.12.112","volume":"17","author":"P Kosmidis","year":"2002","unstructured":"Kosmidis P, Mylonakis N, Nicolaides C, Kalophonos C, Samantas E, Boukovinas J, Fountzilas G, Skarlos D, Economopoulos T, Tsavdaridis D, Papakostas P, Bacoyiannis C, Dimopoulos M (2002) Paclitaxel plus carboplatin versus gemcitabine plus paclitaxel in advanced non-small-cell lung cancer: a phase III randomized trial. J Clin Oncol 17:3578\u20133585","journal-title":"J Clin Oncol"},{"key":"378_CR16","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1200\/JCO.2004.10.576","volume":"22","author":"E Laack","year":"2004","unstructured":"Laack E, Dickgreber N, Muller T, Knuth A, Benk J, Lorenz C, Gieseler F, Durk H, Engel-Riedel W, Dalhoff K, Kortsik C, Graeven U, Burk M, Dierlamm T, Welte T, Burkholder I, Edler L, Hossfeld DK, German and Swiss Lung Cancer Study Group (2004) Randomized phase III study of gemcitabine and vinorelbine versus gemcitabine, vinorelbine and cisplatin in the treatment of advanced non-small-cell lung cancer: from the german and swiss lung cancer study group. J Clin Oncol 22:2348\u20132356","journal-title":"J Clin Oncol"},{"key":"378_CR10","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1002\/cncr.22049","volume":"107","author":"SJ Mandrecar","year":"2006","unstructured":"Mandrecar SJ, Schild SE, Hillman SL, Allen KL, Marks RS, Mailliard JA, Krook JE, Maksymiuk AW, Chansky K, Kelly K, Adjei AA, Jett JR (2006) A prognostic model for advanced stage non-small cell lung cancer. Cancer 107:781\u2013792","journal-title":"Cancer"},{"key":"378_CR6","doi-asserted-by":"crossref","unstructured":"Paesmans M, Sculier JP, Libert P, Bureau G, Dabouis G, Thiriaux J, Michel J, Van Cutsem O, Sergysels R, Mommen P, Klastersky J, for the European Lung Cancer Working Party (1995) Prognostic factors for survival in advanced non-small-cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1,052 patients. J Clin Oncol 13:1221\u20131230","DOI":"10.1200\/JCO.1995.13.5.1221"},{"key":"378_CR12","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/sj.bjc.6602702","volume":"93","author":"H Schmidt","year":"2005","unstructured":"Schmidt H, Bastholt L, Geertsen P, Christensen IJ, Larsen S, Gehl J, von der Maase H (2005) Elevated neutrophil and monocyte counts in peripheral blood are associated with poor survival in patients with metastatic melanoma: a prognostic model. Br J Cancer 93:273\u2013278","journal-title":"Br J Cancer"},{"key":"378_CR8","doi-asserted-by":"crossref","first-page":"8380","DOI":"10.1200\/JCO.2005.01.2781","volume":"23","author":"C Sederholm","year":"2005","unstructured":"Sederholm C, Hillerdal G, Lamberg K, Kolbeck K, Dufmats M, Westberg R, Gawande SR (2005) Phase III trial of gemcitabine plus carboplatin versus single-agent gemcitabine in the treatment of locally advanced or metastatic non-small-cell lung cancer: the Swedish lung cancer study group. J Clin Oncol 23:8380\u20138388","journal-title":"J Clin Oncol"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-008-0378-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00432-008-0378-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-008-0378-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T03:46:47Z","timestamp":1738122407000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00432-008-0378-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3,18]]},"references-count":16,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["378"],"URL":"https:\/\/doi.org\/10.1007\/s00432-008-0378-2","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,3,18]]}}}